Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018146297) METHOD FOR GENERATING T CELLS PROGENITORS
Latest bibliographic data on file with the International Bureau    Submit observation
Pub. No.: WO/2018/146297 International Application No.: PCT/EP2018/053406
Publication Date: 16.08.2018 International Filing Date: 12.02.2018
IPC:
C12N 5/0783 (2010.01) ,A61K 35/17 (2015.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07
Animal cells or tissues
071
Vertebrate cells or tissues, e.g. human cells or tissues
078
Cells from blood or from the immune system
0783
T cells; NK cells; Progenitors of T or NK cells
[IPC code unknown for A61K 35/17]
Applicants:
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS [FR/FR]; 3, avenue Victoria 75004 PARIS, FR
FONDATION IMAGINE - INSTITUT DES MALADIES GÉNÉTIQUES [FR/FR]; 24, boulevard du Montparnasse 75015 PARIS, FR
UNIVERSITÉ PARIS DESCARTES [FR/FR]; 12, rue de l'École de Médecine 75006 PARIS, FR
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM) [FR/FR]; 101, rue de Tolbiac 75013 PARIS, FR
Inventors:
ANDRÉ-SCHMUTZ, Isabelle; FR
CAVAZZANA, Marina; FR
MA, Kuiying; FR
TCHEN, John; FR
Agent:
ICOSA; 83 avenue Denfert-Rochereau 75014 Paris, FR
Priority Data:
17305161.613.02.2017EP
Title (EN) METHOD FOR GENERATING T CELLS PROGENITORS
(FR) PROCÉDÉ PERMETTANT DE PRODUIRE DES PROGÉNITEURS DE LYMPHOCYTES T
Abstract:
(EN) The invention relates to an in vitro method to generate T cell progenitors, comprising the step of culturing CD34+ cells in a medium containing TNF-alpha and/or an antagonist of the Aryl hydrocarbon/Dioxin receptor, in particular StemRegenin 1 (SR1), in presence of a Notch ligand and optionally a fibronectin fragment.
(FR) L'invention concerne un procédé in vitro pour produire des progéniteurs de lymphocytes T, comprenant l'étape consistant à mettre en culture des cellules CD34+ dans un milieu contenant du TNF-alpha et/ou un antagoniste du récepteur d'hydrocarbure d'aryle/dioxine, en particulier StemRegenin 1 (SR1), en présence d'un ligand Notch et éventuellement d'un fragment de fibronectine.
 front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)